Prevention

Feature Article

Breathing New Life Into COPD and Asthma Therapy With Statins

Breathing New Life Into COPD and Asthma Therapy With Statins

Statins have anti-inflammatory and anti-oxidative effects, which could reduce exacerbations of both asthma and chronic obstructive pulmonary disease.

Latest Features

Breathing New Life Into COPD and Asthma Therapy With Statins

Breathing New Life Into COPD and Asthma Therapy With Statins

Statins have anti-inflammatory and anti-oxidative effects, which could reduce exacerbations of both asthma and chronic obstructive pulmonary disease.

AHA Examines CVD and Breast Cancer Relationship

AHA Examines CVD and Breast Cancer Relationship

The American Heart Association has released a scientific statement examining the relationship between cardiovascular disease and breast cancer.

The Mounting Evidence Against Electronic Cigarette Use

The Mounting Evidence Against Electronic Cigarette Use

Electronic cigarettes were once thought to be a helpful smoking cessation tool, but new evidence suggests they may be as if not more harmful than combustible cigarettes.

Semaglutide May Be Useful for Treating Obesity in People Without Diabetes

Semaglutide May Be Useful for Treating Obesity in People Without Diabetes

In combination with dietary and physical activity counseling, all semaglutide doses from 0.05-0.4 mg daily were tolerated and resulted in dose-related reductions in body weight among people with obesity without diabetes.

The Connection Between Cardiovascular Disease and Sleep Apnea: An Expert Interview

The Connection Between Cardiovascular Disease and Sleep Apnea: An Expert Interview

To examine the link between cardiovascular disease and sleep apnea, The Cardiology Advisor spoke with cardiologist Seth S. Martin, MD, MHS, FACC, FAHA and sleep specialist Rachel Marie E. Salas, MD, FAAN.

Digital Adherence Devices: Preventing Strokes in Afib One Reminder at a Time

Digital Adherence Devices: Preventing Strokes in Afib One Reminder at a Time

Using digital adherence devices to improve medication adherence in patients with atrial fibrillation may reduce the rate of ischemic strokes.

Beyond a Respiratory Disease: Cardiovascular Complications of Pneumonia

Beyond a Respiratory Disease: Cardiovascular Complications of Pneumonia

Pre-existing cardiovascular disease is the strongest risk factor for cardiovascular complications in patients with pneumonia.

Sudden Death in Young Athletes: Screening, Risk Factors, and Prevention

Sudden Death in Young Athletes: Screening, Risk Factors, and Prevention

Evaluating screening and prevention for sudden death in young athletes.

Reducing Neurologic Damage After Stroke With Ischemic Preconditioning

Reducing Neurologic Damage After Stroke With Ischemic Preconditioning

Ischemic preconditioning may provide neuroprotective effects that reduce stroke infarct size and improve recovery times.

Cardiovascular Disease Risks With Fertility Treatment: What We Know

Cardiovascular Disease Risks With Fertility Treatment: What We Know

The underlying cause of infertility is a major variable in confirming the link between fertility treatment and cardiovascular disease.

Latest News

AHA: Assessment and Promotion of Physical Activity for CVD Prevention

AHA: Assessment and Promotion of Physical Activity for CVD Prevention

The American Heart Association provided updated guidelines for the routine assessment of physical activity for healthcare systems and providers as a way to prevent future health complications.

Loading Atorvastatin Doses Before and After PCI in ACS for MACE Prevention

Loading Atorvastatin Doses Before and After PCI in ACS for MACE Prevention

Major adverse cardiovascular events were not reduced in patients with acute coronary syndrome undergoing planned percutaneous coronary intervention when given 2 loading doses of atorvastatin.

Psoriasis Treatment Ixekizumab Safe for Cardiovascular Health

Psoriasis Treatment Ixekizumab Safe for Cardiovascular Health

Biologic therapies for psoriasis may have an impact on cardiovascular parameters, potentially resulting in the occurrence of major adverse cardiovascular events.

Increased Risk for Mortality in People With Diabetes, CHD Taking Beta-Blockers

Increased Risk for Mortality in People With Diabetes, CHD Taking Beta-Blockers

Further studies are needed to assess whether beta-blockers are effective in reducing mortality and coronary events in patients with diabetes receiving optimal medical treatment.

Praxbind Gains Full FDA Approval as Pradaxa Reversal Agent

Praxbind Gains Full FDA Approval as Pradaxa Reversal Agent

Complete reversal was seen within 4 hours in the majority of patients, as measured by ecarin clotting time (ECT 82%) or diluted thrombin time (dTT 99%). In addition, there was a low late of thrombotic events and no new safety events were reported.

Medication Adherence, Blood Pressure Reduction Assessed With Smartphone App Use

Medication Adherence, Blood Pressure Reduction Assessed With Smartphone App Use

While smartphone app use led to increased medication adherence, corresponding drops in systolic blood pressure were not seen.

Statin Prescription Trends in Women vs Men After Hospitalization for MI

Statin Prescription Trends in Women vs Men After Hospitalization for MI

Women are less likely than men to fill a high-intensity statin prescription following hospitalization for myocardial infarction.

Menopause Symptom Severity May Predict Heart Disease

Menopause Symptom Severity May Predict Heart Disease

Researchers examined whether menopausal symptoms, quality of life, and depression are related to arterial stiffness, a risk factor for cardiovascular disease.

Canagliflozin Reduces CV Death and Hospitalizations for Heart Failure in T2D

Canagliflozin Reduces CV Death and Hospitalizations for Heart Failure in T2D

Patients with type 2 diabetes at risk for heart failure are particularly likely to benefit from treatment with canagliflozin.

Noninvasive CAD Screening May Reduce Cardiac Events in Individuals With Asymptomatic Diabetes

Noninvasive CAD Screening May Reduce Cardiac Events in Individuals With Asymptomatic Diabetes

Compared with standard care, noninvasive coronary artery disease screening reduced cardiac events by 27% in individuals with asymptomatic diabetes. Results justify larger, appropriately powered trials to potentially revisit current recommendations.

Sign Up for Free e-Newsletters